Emoxypine
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
1
Phase 4
2
Earliest trial started Oct 1, 2014 (NCT02793687)
Timeline
Indications
Approved for
Mechanism of action
- CatalaseACTIVATOR
CAT activator
- Radical scavenging activityACTIVATOR
Radical scavenging activity activator
Chemistry & pharmacology
Loading structure…
SMILES
CCc1nc(C)ccc1O- Mol. weight
- 137.18 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3338326 ↗
Also known as
- ethylmethylhydroxypyridine succinate
- ethylmethylhydroxypyridine succinate
- ethylmethylhydroxypyridine succinate
- mexicor
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05939622 | Phase 4 | May 18, 2022 | Promomed, LLC |
| NCT05689827 | Phase 4 | Apr 5, 2022 | Promomed, LLC |
| NCT04608760 | Phase 1 | Aug 1, 2020 | Vitebsk State Medical University |
| NCT02793687 | Phase 3 | Oct 1, 2014 | Pharmasoft |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Promomed, LLC | For profit | 2 | 2 | 1 | 2022 |
| Pharmasoft | For profit | 1 | 1 | 1 | 2014 |
| Vitebsk State Medical University | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1